Market Signal Briefing

Shares of Wix.com (WIX +1.15%) fell 18.9% in February, according to data from S&P Global Market Intelligence. Investors have feared that artificial intelligence (AI) will disrupt Wix's core website-building platform, yet when the business reported earnings in early March, it showed strong growth, leading the stock to rebound all its losses from February.

Wix's stock is still down 73.4% from all-time highs. Here's why it fell in February before rebounding in March, and whether it is a buy for your portfolio right now.

Today's Change

(

1.15

%) $

1.07

Current Price

$

94.01

A narrative that didn't line up with reality Wix.com is a website-building platform that has focused on the individual and small-business market, such as a local restaurant. It allows people to easily build their own website without coding, publish it on the web, and add tools such as payment processing to make it easier to manage customer relationships.

Over the last few months, investors have feared that software such as Wix could be disrupted by AI. Chatbots like Claude or Gemini can help build website templates very easily by just having a conversation with them, which some fear could mean the end of Wix's subscription business. This is why the stock was consistently dropping leading into its Q4 earnings report on March 4th.

The results spoke a slightly different tune, with revenue growing 14% year-over-year during the period, and with healthy cash flow. Wix's business is also benefiting from the fast growth of its recent acquisition of Base44, an application-building platform built on top of AI chatbots like Claude. It has already surpassed $100 million in annual recurring revenue (ARR).

Image source: Getty Images.

Should you buy Wix.com stock? Management certainly seems to think Wix stock is a good buy right now. It has authorized the repurchase of up to $2 billion in shares, which it plans to do this calendar year, if possible. Today, Wix has a market cap of just $5 billion, meaning it could retire 40% of its shares outstanding in 2026 alone.

The company has the cash flow and balance sheet to do it, meaning it wants to aggressively return capital to shareholders and take advantage of this cheap share price. Currently, the stock has a price-to-free cash flow (P/FCF) of 8.9, making it one of the cheapest software stocks on the market today.

Even after rebounding following this earnings report, Wix stock could be a solid buy for any investor's portfolio in 2026.

SAN DIEGO, March 08, 2026 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of NuScale Power Corporation (NYSE: SMR) Class A common stock between May 13, 2025 and November 6, 2025, inclusive (the “Class Period”), have until Monday, April 20, 2026 to seek appointment as lead plaintiff of the NuScale class action lawsuit. Captioned Truedson v. NuScale Power Corporation, No. 26-cv-00328 (D. Or.), the NuScale class action lawsuit charges NuScale, certain NuScale top executive officers, and Fluor Corporation with violations of the Securities Exchange Act of 1934.

If you suffered substantial losses and wish to serve as lead plaintiff of the NuScale class action lawsuit, please provide your information here:

https://www.rgrdlaw.com/cases-nuscale-power-class-action-lawsuit-smr.html

You can also contact attorney J.C. Sanchez of Robbins Geller by calling 800/449-4900 or via e-mail at [email protected].

CASE ALLEGATIONS: NuScale’s core technology, the NuScale Power Module (“NPM”), is a small modular nuclear reactor designed to generate energy within a broader power plant. Prior to the start of the Class Period, NuScale entered into a global commercialization partnership with ENTRA1 Energy LLC and NuScale and its executives claimed that this critical partnership would allow NuScale to take its NPM technology from the development stage to deployment. NuScale’s reliance on ENTRA1 as an exclusive commercialization partner appeared to be validated when, on September 2, 2025, ENTRA1 and the Tennessee Valley Authority (“TVA”) jointly announced an agreement to develop power plants to provide the TVA with up to six gigawatts of new nuclear power generation.

However, the NuScale class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) ENTRA1 had never built, financed, or operated any significant projects – let alone projects in the highly technical and complicated field of nuclear power generation – during its entire operating history; (ii) NuScale had entrusted its commercialization, distribution, and deployment of its NPMs and hundreds of millions of dollars of NuScale capital to an entity that lacked any significant prior experience owning, financing, or operating nuclear energy generation facilities; (iii) the purported experience and qualifications attributed to ENTRA1 by defendants during the Class Period in fact referred to the purported experience and qualifications of the principals of the Habboush Group, a distinct entity without significant experience in the field of nuclear power generation; and (iv) as a result, NuScale’s commercialization strategy was exposed to material, undisclosed risks of failure, delays, regulatory challenges, or other negative setbacks.

The NuScale investor class action further alleges that on November 6, 2025 NuScale revealed that NuScale’s general and administrative expenses had ballooned more than 3,000% to $519 million during its third fiscal quarter, up from $17 million in the prior year period, due largely to NuScale’s payment of $495 million to ENTRA1 for its TVA agreement. As a result, NuScale’s quarterly net loss skyrocketed to $532 million, up from $46 million in the prior year period. During the corresponding conference call, analysts pressed NuScale management regarding whether ENTRA1 was sufficiently experienced to own and operate the energy generation facilities contemplated by the TVA agreement. NuScale’s CEO, defendant John L. Hopkins, further revealed during the call that the agreement between ENTRA1 and TVA contemplated as many as 72 NPMs, meaning NuScale’s milestone payments to ENTRA1 could potentially exceed more than $3 billion. On this news, the price of NuScale Class A shares declined more than 12% over a two-day trading period.

The plaintiff is represented by Robbins Geller, which has extensive experience in prosecuting investor class actions including actions involving financial fraud. You can view a copy of the complaint by clicking here.

THE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased NuScale Class A common stock during the Class Period to seek appointment as lead plaintiff in the NuScale class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the NuScale class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the NuScale class action lawsuit. An investor’s ability to share in any potential future recovery of the NuScale class action lawsuit is not dependent upon serving as lead plaintiff.

ABOUT ROBBINS GELLER: Robbins Geller Rudman & Dowd LLP is one of the world’s leading law firms representing investors in securities fraud and shareholder rights litigation. Our Firm ranked #1 on the most recent ISS Securities Class Action Services Top 50 Report, recovering more than $916 million for investors in 2025. This marks our fourth #1 ranking in the past five years. And in those five years alone, Robbins Geller recovered $8.4 billion for investors – $3.4 billion more than any other law firm. With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs’ firms in the world, and the Firm’s attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever – $7.2 billion – in In re Enron Corp. Sec. Litig. Please visit the following page for more information:

https://www.rgrdlaw.com/services-litigation-securities-fraud.html

Past results do not guarantee future outcomes. 
Services may be performed by attorneys in any of our offices. 

Contact:
        Robbins Geller Rudman & Dowd LLP
        J.C. Sanchez
        655 W. Broadway, Suite 1900, San Diego, CA 92101
        800-449-4900
        [email protected]

Popular crypto analyst known under the nickname PlanB, the creator of the Stock-to-Flow S2F model, has presented an updated Bitcoin outlook. According to it, the average price in the current 2024-2028 cycle may reach $500,000 per BTC.

Peter Zhang Mar 08, 2026 18:12

AVAX Price Prediction Summary • Short-term target (1 week): $9.50-$9.80 • Medium-term forecast (1 month): $10.50-$12.00 range • Bullish breakout level: $9.11 • Critical support:...

AVAX Price Prediction Summary • Short-term target (1 week): $9.50-$9.80 • Medium-term forecast (1 month): $10.50-$12.00 range
• Bullish breakout level: $9.11 • Critical support: $8.65

What Crypto Analysts Are Saying About Avalanche Recent analyst forecasts remain optimistic for Avalanche despite current price consolidation. Alvin Lang from Blockchain.News recently stated: "Avalanche (AVAX) trades at $9.05 with analysts forecasting $10.50-$12.00 targets by month-end. Technical indicators show neutral momentum with key resistance at $9.52."

Earlier in the week, Lang maintained similar targets, noting "Avalanche (AVAX) trades at $9.13 with analysts targeting $10.50-$12.00 by March end. Technical indicators show neutral RSI at 46.21 with key resistance at $9.78."

Ted Hisokawa from MEXC News also provided a bullish outlook, observing: "Avalanche shows 6.84% daily gains with AVAX targeting $10.50 by month-end. Technical indicators suggest consolidation before potential breakout above $10 resistance."

These analyst predictions align with technical patterns suggesting AVAX is preparing for a significant move, though the direction remains dependent on breaking key resistance levels.

AVAX Technical Analysis Breakdown Current technical indicators paint a mixed picture for this AVAX price prediction. Trading at $8.84, Avalanche sits below most moving averages, with the 7-day SMA at $9.14 and 20-day SMA at $9.03 providing immediate resistance.

The RSI reading of 42.67 indicates neutral territory, neither oversold nor overbought, suggesting room for movement in either direction. The MACD histogram at 0.0000 shows bearish momentum has stalled, potentially setting up for a reversal.

Within the Bollinger Bands, AVAX trades at position 0.34, closer to the lower band ($8.42) than the upper band ($9.65), indicating potential for upward movement if buying pressure emerges. The daily ATR of $0.60 suggests moderate volatility levels.

Key resistance levels stand at $8.98 (immediate) and $9.11 (strong), while support levels are positioned at $8.75 (immediate) and $8.65 (strong). The 24-hour trading range of $8.79-$9.02 reflects the current consolidation pattern.

Avalanche Price Targets: Bull vs Bear Case Bullish Scenario In the optimistic case for this Avalanche forecast, a break above the strong resistance at $9.11 could trigger momentum toward the analyst targets of $10.50-$12.00. The path higher would likely test the 50-day SMA at $9.90 before challenging the psychological $10 level.

Technical confirmation would require sustained trading above $9.11 with increased volume, potentially pushing AVAX toward the upper Bollinger Band at $9.65 as an intermediate target. A successful breach of $10 resistance could accelerate gains toward the $10.50-$12.00 range projected by analysts.

Bearish Scenario The downside risk for this AVAX price prediction centers on a breakdown below the critical support at $8.65. Such a move could expose the lower Bollinger Band at $8.42 and potentially trigger further selling pressure.

Risk factors include broader crypto market weakness, continued consolidation below moving averages, and failure to generate buying interest above current levels. A break below $8.42 could signal a deeper correction toward the $8.00-$8.20 zone.

Should You Buy AVAX? Entry Strategy For this Avalanche forecast, potential entry strategies depend on risk tolerance and market conviction. Conservative buyers might wait for a confirmed breakout above $9.11 with volume, targeting the $9.50-$9.80 range initially.

Aggressive traders could consider accumulating near current support levels around $8.75-$8.84, with a stop-loss below $8.65. This approach offers better risk-reward if the analyst targets of $10.50-$12.00 materialize.

Risk management suggests position sizing appropriate for the volatility, with the daily ATR of $0.60 indicating potential for significant daily moves. Consider scaling into positions rather than single large entries.

Conclusion This AVAX price prediction suggests cautious optimism for Avalanche over the remainder of March. While current technical indicators show neutral momentum, multiple analysts maintain targets of $10.50-$12.00, representing potential upside of 19-36% from current levels.

The key catalyst remains breaking above the $9.11 resistance level, which could unlock the projected gains. However, traders should monitor the critical support at $8.65, as a breakdown could invalidate the bullish scenario.

Confidence Level: Moderate (65%) - Technical consolidation requires confirmation

Disclaimer: Cryptocurrency price predictions are speculative and based on technical analysis and market sentiment. Digital assets are highly volatile and carry significant risk. Always conduct your own research and never invest more than you can afford to lose.

Image source: Shutterstock

avax price analysis avax price prediction

Canadian billionaire Frank Giustra has warned that Bitcoin (BTC) faces existential risks from quantum computing and artificial intelligence (AI).

In an X post on March 8, the analyst said the cryptocurrency would be fortunate to survive the next five years.

Giustra made the remark in response to a video clip featuring Block co-founder Jack Dorsey and Strategy executive chairman Michael Saylor. 

Centuries? They will be lucky to survive AI and Quantum computing in the next 5 years.

— Frank Giustra (@Frank_Giustra) March 8, 2026 The clip, shared by Bitcoin infrastructure provider Maestro, shows Saylor emphasizing Bitcoin’s self-custody capability, which he said gives it ethical and moral superiority over most digital securities and supports projections that the network could endure for a century.

Dorsey echoed the view, highlighting Bitcoin’s slow and predictable upgrade process compared with faster-moving alternatives like Ethereum (ETH), and expressing confidence that this approach could allow it to function as an internet-native currency serving billions for decades.

Notably, the two experts agreed that the asset could keep increasing in value for centuries.

Giustra dismissed the claim, saying centuries-long durability is unrealistic given accelerating technological threats, and added that Bitcoin will be lucky to survive AI and quantum computing within five years.

The mining financier and longtime gold advocate has frequently criticized Bitcoin as a speculative asset rather than a reliable store of value, arguing its transparent blockchain could make it more vulnerable to government seizure than physical gold.

His main concern is quantum computing’s potential to undermine Bitcoin’s security through algorithms such as Shor’s, which could derive private keys from exposed public keys and compromise elliptic curve–based signatures. 

Roughly 25% of Bitcoin’s supply, including older or dormant addresses, could be vulnerable if sufficiently powerful quantum computers emerge.

Progress in quantum computing  Recent advances in quantum hardware have intensified the debate. For instance, companies such as Google, IBM, Quantinuum, and PsiQuantum have reported progress in qubit counts, gate fidelity, and error-corrected systems, while PsiQuantum has accelerated construction of large-scale facilities.

However, most experts say a quantum computer capable of threatening Bitcoin remains years away. Some researchers, including BIP-360 co-author Ethan Heilman, estimate Bitcoin has about seven years to achieve meaningful quantum resistance if upgrades begin soon, given the coordination and adoption required across the network.

Developers have already begun addressing the risk. For instance, in February 2026, BIP 360, titled Pay-to-Merkle-Root, was published in the Bitcoin Improvement Proposals repository for review. 

The proposal introduces a new output type that hides vulnerable public keys, similar to Taproot, while removing quantum-exposed keypath spends.

It has not been activated and would likely require additional proposals and years of community consensus.

Industry estimates, including from Citi Institute, place the probability of widespread public-key breakage at 19% to 34% by 2034, rising further by 2044. 

Most cybersecurity and blockchain experts emphasize preparation rather than predicting imminent failure, while government plans, such as U.S. timelines to transition critical infrastructure to quantum-safe systems between 2030 and 2035, reflect similar caution.

Featured image from Shutterstock.

Darius Baruo Mar 08, 2026 18:18

LINK Price Prediction Summary • Short-term target (1 week): $8.89 • Medium-term forecast (1 month): $8.33-$9.70 range • Bullish breakout level: $9.70 • Critical support: $8.33 What Crypto An...

LINK Price Prediction Summary • Short-term target (1 week): $8.89 • Medium-term forecast (1 month): $8.33-$9.70 range
• Bullish breakout level: $9.70 • Critical support: $8.33

What Crypto Analysts Are Saying About Chainlink While specific analyst predictions are currently limited, recent commentary from Ali Charts (@alicharts) on January 5, 2026, suggested that "Chainlink $LINK could continue pushing toward the top of the channel at $14.63," indicating a longer-term bullish outlook despite current price weakness.

However, this ambitious target appears disconnected from current technical realities, as LINK trades significantly below this level. According to on-chain data, Chainlink's current positioning suggests a more cautious near-term outlook, with the token struggling to maintain momentum above key support zones.

LINK Technical Analysis Breakdown Chainlink's technical picture presents a mixed but predominantly bearish setup. Trading at $8.54, LINK sits below all major moving averages except the 20-day SMA at $8.80, indicating sustained downward pressure.

The RSI reading of 42.78 places LINK in neutral territory, suggesting oversold conditions haven't been reached yet but momentum is clearly weakening. The MACD histogram at 0.0000 shows bearish momentum, though the lack of divergence suggests selling pressure may be stabilizing.

Bollinger Bands analysis reveals LINK trading in the lower portion of the bands with a %B position of 0.2808, indicating the token is closer to oversold than overbought conditions. The daily ATR of $0.61 suggests moderate volatility, providing reasonable trading opportunities within the current range.

Key resistance emerges at $8.89, representing the strongest near-term barrier, while immediate support sits at $8.43. The broader trading range between $8.33 (strong support) and $9.70 (SMA 50) will likely contain LINK price action in the coming weeks.

Chainlink Price Targets: Bull vs Bear Case Bullish Scenario A successful break above $8.89 resistance could trigger a move toward the SMA 50 at $9.70, representing a 13.6% upside from current levels. This Chainlink forecast would require sustained buying volume and broader crypto market support.

The bullish case strengthens significantly if LINK can reclaim the 20-day SMA at $8.80 and hold above it for multiple daily closes. Such technical confirmation could attract algorithmic buying and push the token toward the upper Bollinger Band at $9.38 as an intermediate target.

Bearish Scenario Failure to hold the $8.43 support level opens the door to a test of strong support at $8.33. A breakdown below this critical level could trigger accelerated selling toward the lower Bollinger Band at $8.21, representing a 4% decline from current prices.

The most concerning scenario involves a break below $8.21, which could signal a deeper correction toward psychological support levels. Given the distance below the SMA 200 at $15.47, LINK remains in a long-term downtrend that could persist without significant fundamental catalysts.

Should You Buy LINK? Entry Strategy Conservative buyers should wait for a successful test and hold of the $8.43 support level before considering entry. A bounce from this level with increased volume would provide better risk-reward dynamics for new positions.

More aggressive traders might consider dollar-cost averaging between $8.33-$8.54, with tight stop-losses below $8.21 to limit downside exposure. The proximity to the lower Bollinger Band suggests limited downside risk from current levels.

Position sizing should remain conservative given the bearish MACD signal and distance below major moving averages. A stop-loss at $8.15 would provide approximately 4.6% maximum loss while allowing room for normal market fluctuations.

Conclusion This LINK price prediction suggests a cautious outlook with potential for a bounce toward $9.70 over the next month. While oversold conditions are developing, the lack of clear bullish catalysts limits upside potential in the near term.

The most likely scenario involves continued range-bound trading between $8.33-$9.70, with any sustainable rally requiring broader crypto market strength. Traders should focus on risk management and avoid aggressive positioning until clearer directional signals emerge.

Disclaimer: Cryptocurrency investments carry significant risk. This analysis is for informational purposes only and should not be considered financial advice. Always conduct your own research and consider your risk tolerance before making investment decisions.

Image source: Shutterstock

link price analysis link price prediction

Timothy Morano Mar 08, 2026 18:35

Cosmos (ATOM) trades at $1.73 with oversold RSI at 33.64, presenting potential recovery opportunity to $2.40 resistance level as technical indicators suggest bounce from critical support zones.

ATOM Price Prediction Summary • Short-term target (1 week): $1.82 • Medium-term forecast (1 month): $2.40-$2.80 range
• Bullish breakout level: $2.43 • Critical support: $1.68

What Crypto Analysts Are Saying About Cosmos Recent analyst predictions from early March provide insight into ATOM's potential trajectory. Rebeca Moen noted on March 4, 2026: "Cosmos (ATOM) trades at $1.84 with oversold conditions presenting recovery opportunity. Technical analysis suggests potential bounce to $2.40 resistance as ATOM approaches critical support zones."

Similarly, Tony Kim observed on March 2, 2026: "ATOM price prediction shows potential recovery to $2.40 as Cosmos trades oversold at $1.80. Technical analysis reveals critical support holding with bullish signals emerging."

Iris Coleman provided a slightly more optimistic Cosmos forecast on February 26, suggesting: "Cosmos (ATOM) faces critical support at $1.79 with RSI at 39.12. Technical analysis suggests potential recovery to $2.45-$2.80 range if key resistance breaks."

The consensus among analysts points toward a $2.40-$2.80 recovery target, contingent on ATOM holding current support levels and breaking through immediate resistance.

ATOM Technical Analysis Breakdown Current technical indicators paint a mixed but potentially bullish picture for Cosmos. Trading at $1.73, ATOM has declined 3.40% in the past 24 hours but shows signs of potential reversal.

The RSI reading of 33.64 indicates neutral territory with room for upward movement, while the asset's position at 0.19 on the Bollinger Bands scale places it near the lower band at $1.57, suggesting oversold conditions that could trigger a bounce.

Moving averages tell a bearish story with ATOM trading below all major timeframes - the 7-day SMA at $1.81, 20-day at $2.00, and critically below the 200-day at $2.92. However, the proximity to the 7-day average suggests potential for a quick recovery.

The MACD histogram at 0.0000 indicates neutral momentum, while the extremely low Stochastic readings (%K at 1.69, %D at 1.35) suggest ATOM is deeply oversold and due for a technical bounce.

Cosmos Price Targets: Bull vs Bear Case Bullish Scenario In a bullish scenario, ATOM price prediction targets the immediate resistance at $1.78, followed by the strong resistance at $1.82. Breaking above these levels could propel Cosmos toward the Bollinger Band middle line at $2.00, aligning with the 20-day SMA.

The ultimate bullish target sits at the upper Bollinger Band of $2.43, which coincides with analyst predictions around $2.40. A sustained move above $2.43 could open the door to the $2.80 range predicted by some analysts.

Technical confirmation would require RSI moving above 50 and MACD turning positive, alongside volume expansion above the current $1.64 million daily average.

Bearish Scenario The bearish case for this ATOM price prediction centers on a break below the immediate support at $1.70. Such a move could trigger stops and push ATOM toward the strong support at $1.68.

A failure to hold $1.68 could see Cosmos testing the lower Bollinger Band at $1.57, representing approximately a 9% downside from current levels. Below this level, ATOM could face a more significant correction toward psychological support levels.

Risk factors include broader crypto market weakness, regulatory concerns affecting the Cosmos ecosystem, or technical breakdown below key moving averages.

Should You Buy ATOM? Entry Strategy For those considering ATOM, the current oversold conditions present a potential entry opportunity, though patience may be rewarded. The ideal entry strategy would involve:

Primary Entry Zone: $1.68-$1.70 (current strong support area) Secondary Entry: $1.57 (lower Bollinger Band bounce) Stop-Loss: Below $1.55 (approximately 10% risk from primary entry)

First target: $1.82 (immediate resistance) Second target: $2.00 (20-day SMA) Extended target: $2.40 (analyst consensus) Risk management should limit exposure to 2-3% of portfolio value given the volatility indicated by the daily ATR of $0.11.

Conclusion This ATOM price prediction suggests a cautiously optimistic outlook for Cosmos in the coming weeks. With oversold technical indicators, analyst targets around $2.40, and critical support levels holding, ATOM appears positioned for a potential 25-40% recovery from current levels.

However, the Cosmos forecast remains dependent on broader market conditions and the ability to break through immediate resistance levels. The confluence of oversold RSI, analyst predictions, and Bollinger Band positioning supports a bullish bias, though risk management remains crucial.

Confidence Level: Moderate (60-65% probability of reaching $2.40 within 30 days)

This analysis is for educational purposes only and should not be considered financial advice. Cryptocurrency investments carry significant risk, and past performance does not guarantee future results. Always conduct your own research and consider consulting with a financial advisor before making investment decisions.

Image source: Shutterstock

atom price analysis atom price prediction

Joerg Hiller Mar 08, 2026 18:47

TRON (TRX) consolidates at $0.29 with mixed signals. Technical analysis suggests potential breakout toward $0.32-$0.35 resistance zone despite bearish MACD momentum.

TRON (TRX) is currently trading at $0.29, showing modest gains of 1.23% over the past 24 hours. With the cryptocurrency market entering a critical phase, traders are closely watching TRX for potential breakout signals as it consolidates near key technical levels.

TRX Price Prediction Summary • Short-term target (1 week): $0.30 • Medium-term forecast (1 month): $0.32-$0.35 range • Bullish breakout level: $0.32 • Critical support: $0.28

What Crypto Analysts Are Saying About TRON Recent analyst predictions from early March 2026 provide insight into TRX's potential trajectory. Rebeca Moen noted on March 2 that "TRON trades at $0.28 with neutral RSI at 45.90. Technical analysis suggests TRX could test $0.29 resistance, but bearish MACD signals caution for March targets," setting a target of $0.29.

James Ding echoed similar sentiment on March 3, observing that "TRON trades at $0.28 with neutral RSI at 46.88. Technical analysis suggests TRX could test $0.29 resistance, though bearish MACD signals warrant caution for March targets," also targeting $0.29.

More optimistically, Alvin Lang predicted on March 4 that "TRON (TRX) consolidates at $0.28 with neutral RSI signals. Technical analysis suggests potential breakout toward $0.32-$0.35 resistance zone amid mixed momentum indicators," providing a higher target range of $0.32-$0.35.

According to on-chain data platforms, TRON's network activity and trading patterns suggest the token is positioned for potential upward movement, though mixed technical signals require careful analysis.

TRX Technical Analysis Breakdown The current TRON forecast reveals a mixed technical picture that demands careful interpretation. TRX's RSI sits at 56.42, indicating neutral momentum without clear overbought or oversold conditions. This neutral reading suggests room for movement in either direction.

The MACD analysis presents concerning signals with a histogram reading of 0.0000, indicating bearish momentum despite the price holding steady. The MACD line at 0.0002 barely differs from the signal line at 0.0002, suggesting indecision in the market.

Bollinger Bands analysis shows TRX trading near the upper band with a %B position of 0.8995, indicating the price is close to resistance levels. The upper band at $0.29 aligns with current price action, while the middle band (20-day SMA) sits at $0.28, providing immediate support.

Moving averages present a mixed outlook with the 7-day SMA at $0.29 matching current price levels, while the 20-day SMA at $0.28 provides support. The 200-day SMA at $0.30 acts as a key resistance level that TRX must break to confirm bullish momentum.

TRON Price Targets: Bull vs Bear Case Bullish Scenario In the bullish case for this TRX price prediction, a break above the $0.30 resistance (200-day SMA) could trigger momentum toward the $0.32-$0.35 target range identified by analysts. The Stochastic indicators show %K at 89.43 and %D at 71.54, suggesting potential for continued upward movement despite approaching overbought levels.

Key technical confirmation would require sustained trading above $0.30 with increased volume, potentially pushing TRX toward the $0.32 level initially, with $0.35 as an extended target if momentum persists.

Bearish Scenario The bearish scenario sees TRX failing to break above current resistance levels, with the bearish MACD histogram signaling potential downward pressure. A break below the $0.28 support level could trigger selling toward lower supports, though specific downside targets remain limited based on current technical data.

Risk factors include broader cryptocurrency market weakness and the inability to generate sufficient buying volume to break key resistance levels.

Should You Buy TRX? Entry Strategy Based on current technical analysis, potential entry points for TRX include:

A conservative approach would involve waiting for a pullback to the $0.28 support level (20-day SMA) before entering positions. Aggressive traders might consider entries on breaks above $0.30 with confirmation volume.

Stop-loss levels should be placed below $0.28 to limit downside risk, while profit targets align with the $0.32-$0.35 range suggested by analyst forecasts.

Risk management remains crucial given the mixed technical signals, with position sizing appropriate for the neutral-to-bearish momentum indicators despite bullish price targets.

Conclusion This TRON forecast suggests TRX is positioned for potential upward movement toward the $0.32-$0.35 range by month-end, supported by analyst predictions and technical breakout patterns. However, bearish MACD signals and resistance at current levels require caution.

The TRX price prediction carries moderate confidence given the mixed technical indicators, with success dependent on breaking above $0.30 resistance with sustained volume. Traders should monitor these key levels closely and maintain appropriate risk management strategies.

This analysis is for informational purposes only and should not be considered financial advice. Cryptocurrency investments carry significant risk, and past performance does not guarantee future results. Always conduct your own research and consider consulting with financial professionals before making investment decisions.

Image source: Shutterstock

trx price analysis trx price prediction

Iris Coleman Mar 08, 2026 18:59

NEAR Protocol shows neutral momentum at $1.22 with technical analysts targeting $1.76-$1.87 resistance levels as March closes, supported by key moving average confluences.

NEAR Price Prediction Summary • Short-term target (1 week): $1.29 • Medium-term forecast (1 month): $1.76-$1.87 range
• Bullish breakout level: $1.38 • Critical support: $1.16

What Crypto Analysts Are Saying About NEAR Protocol While specific analyst predictions are limited in recent trading sessions, established crypto news platforms have provided technical outlooks for NEAR Protocol. According to Blockchain.News analysis from March 4th, "NEAR Protocol shows mixed signals with RSI at 65.21 and price trading above key moving averages. Technical analysis suggests potential rally to $1.76 resistance level within weeks."

MEXC News further reinforced this NEAR price prediction on March 3rd, stating that "NEAR Protocol targets $1.76-$1.87 by March end as bulls eye upper band breakout." These forecasts align with current technical formations visible in the daily chart structure.

On-chain data from major platforms suggests NEAR Protocol's trading volume remains substantial at $15.78 million on Binance spot markets, indicating sustained interest despite the current consolidation phase.

NEAR Technical Analysis Breakdown NEAR Protocol currently trades at $1.22, representing a modest 0.16% daily gain within a tight $1.19-$1.26 trading range. The technical picture presents a neutral stance with several key indicators providing mixed signals.

The RSI reading of 52.96 positions NEAR in neutral territory, neither overbought nor oversold, suggesting room for movement in either direction. This NEAR Protocol forecast aligns with the current consolidation pattern observed across shorter timeframes.

MACD analysis reveals interesting dynamics with both the main line and signal line converging at 0.0259, while the histogram sits at 0.0000, indicating bearish momentum has stalled but bulls haven't yet regained control. The Stochastic oscillator shows %K at 53.19 and %D at 42.55, further confirming the neutral technical stance.

Bollinger Bands analysis places NEAR at 66.29% of the band width, positioned well above the middle band ($1.14) but still distant from the upper band resistance at $1.38. This positioning suggests potential upside momentum if volume increases.

Moving averages present a mixed picture with NEAR trading above the 20-period SMA ($1.14) and near the 50-period SMA ($1.21), but significantly below the 200-period SMA ($1.96), indicating the longer-term trend remains challenged.

NEAR Protocol Price Targets: Bull vs Bear Case Bullish Scenario The bullish case for this NEAR price prediction centers on a break above the immediate resistance at $1.29, which would target the Bollinger Band upper limit at $1.38. A sustained move above this level could trigger the analyst-predicted rally toward $1.76-$1.87.

Technical confirmation would require RSI pushing above 60 with increasing volume, while MACD histogram turning positive would signal momentum shift. The Daily ATR of $0.12 suggests sufficient volatility exists for these upside moves within the projected timeframe.

Key upside targets include: - Initial resistance: $1.29 - Bollinger upper band: $1.38 - Analyst target zone: $1.76-$1.87

Bearish Scenario The bearish scenario for NEAR Protocol forecast involves a breakdown below the critical $1.19 support level established in today's trading range. Such a move would likely test the strong support zone at $1.16, with further downside potentially reaching the Bollinger lower band at $0.90.

Risk factors include broader crypto market weakness, declining trading volume below the current $15.78 million daily average, and failure to reclaim moving average support levels. The current MACD histogram at zero suggests momentum could easily turn negative with increased selling pressure.

Downside targets include: - Immediate support: $1.19 - Strong support: $1.16 - Bollinger lower band: $0.90

Should You Buy NEAR? Entry Strategy Based on current technical levels, traders could consider accumulating NEAR Protocol on dips toward the $1.19-$1.16 support zone, with stops placed below $1.14 to protect against further downside.

For momentum traders, a break above $1.29 with volume confirmation could provide entry opportunities targeting the $1.38-$1.76 range. The relatively tight daily range suggests lower volatility may precede a significant directional move.

Risk management remains crucial given the neutral technical stance. Position sizing should account for the potential 26% downside to Bollinger lower band support versus the 44% upside to analyst targets.

Conservative investors might wait for clearer directional signals, such as RSI moving above 60 or below 40, before establishing positions.

Conclusion This NEAR price prediction suggests a consolidation period may be nearing completion, with technical analysts targeting $1.76-$1.87 by month-end representing reasonable upside objectives. The current $1.22 price level offers a relatively favorable risk-reward setup for patient investors.

However, the neutral technical indicators and mixed moving average signals warrant caution. NEAR Protocol's ability to reclaim and hold above $1.29 resistance will likely determine whether the bullish analyst forecasts materialize in the coming weeks.

This analysis is for informational purposes only and should not be considered financial advice. Cryptocurrency investments carry substantial risk, and past performance does not guarantee future results. Always conduct your own research and consider consulting with a financial advisor before making investment decisions.

Image source: Shutterstock

near price analysis near price prediction

Michael Saylor has hinted at another Bitcoin purchase for Strategy, formerly MicroStrategy, despite continued losses across Bitcoin and the broader crypto market over the past two days. The hint follows last Monday’s Bitcoin acquisition.

Michael Saylor Bitcoin Purchase Hint Posting on X, Michael Saylor wrote, “The Second Century Begins.” For months, Saylor has previewed Bitcoin acquisitions with weekend posts referencing orange dots before official announcements appear on Monday.

Source: Michael Saylor

The hint arrives even as the crypto market struggles with declining prices and reduced liquidity. Last week, Strategy purchased 3,015 BTC. The company spent roughly $204.1 million at an average price of $67,700 per coin. 

That transaction pushed Strategy’s holdings to 720,737 BTC acquired for about $54.77 billion. The company’s average purchase price currently is near $75,985 per Bitcoin. Strategy remains the largest corporate holder of Bitcoin globally. 

Strategy Financing Signals Growing BTC Capacity There has been increased attention on Strategy’s financing mode. The company’s STRC preferred stock, which Anchorage added to its portfolio, recorded a sharp jump in trading volume earlier this week. On March 6, trading volumes reached $260 million, the highest level recorded in 2026.

Notably, investors often link the preferred stock activity to Strategy’s ability to fund additional Bitcoin purchases. At-the-market offerings tied to the instrument can convert investor demand into capital. That structure has previously financed several large Bitcoin acquisitions.

Analysts therefore describe STRC as a steady institutional bid tied to Bitcoin exposure. However, official confirmation of any new purchase would typically arrive through regulatory filings. 

Such disclosures usually appear in subsequent reports submitted to the U.S. Securities and Exchange Commission. Meanwhile, Saylor has continued emphasizing Bitcoin scarcity during recent public remarks. Last week he stated there is not enough Bitcoin available for everyone. 

BTC Price Outlook and Broader Market Weakness However, the hint comes while Bitcoin trades under pressure. At press time, the BTC price is at $67,292. The price declined roughly 0.5% over the past 24 hours after slipping from levels near $70,000.

The weakness extends across the broader crypto market. According to CryptoQuant analyst Darkfost, macroeconomic headwinds continue weighing on digital assets. The analyst noted that the environment remains difficult for risk-sensitive markets.

Recent economic data has complicated the Federal Reserve’s policy outlook. Sticky inflation persists while unemployment has begun rising again. Meanwhile, demand conditions remain relatively strong.

The latest Nonfarm Payrolls report added further uncertainty to Bitcoin and the broader crypto market. Job losses exceeded expectations by a wide margin. That development increased pressure on policymakers evaluating future monetary decisions.

Liquidity conditions also remain tight across financial markets. According to Darkfost, even major institutions feel the strain. BlackRock recently limited investor withdrawals due to insufficient available liquidity.

Darius Baruo Mar 08, 2026 19:05

APT trades at $0.93 with neutral RSI at 42.34. Technical analysis suggests potential rally to $1.05-$1.24 resistance levels despite current bearish MACD signals for March outlook.

APT Price Prediction Summary • Short-term target (1 week): $0.96-$0.98 • Medium-term forecast (1 month): $1.05-$1.24 range
• Bullish breakout level: $0.98 • Critical support: $0.90

What Crypto Analysts Are Saying About Aptos Recent analyst sentiment on Aptos remains cautiously optimistic despite mixed technical signals. Felix Pinkston noted on March 7, 2026: "APT trades at $0.95 with neutral RSI and mixed signals. Technical analysis suggests potential rally to $1.05-$1.24 resistance levels despite current bearish momentum." His target range of $1.05-$1.24 by March end aligns with earlier predictions.

Joerg Hiller provided similar analysis on March 4, 2026, stating: "Aptos (APT) trades at $0.99 with neutral RSI at 47.93. Technical analysis suggests potential rally to $1.05-$1.24 resistance levels, though mixed signals warrant cautious optimism for March outlook."

Both analysts maintain consistent price targets despite acknowledging the challenging technical environment, suggesting the $1.05-$1.24 range represents realistic upside potential for this APT price prediction.

APT Technical Analysis Breakdown Current technical indicators present a mixed picture for Aptos. The RSI sits at 42.34, indicating neutral momentum with room for upward movement before reaching overbought territory. However, the MACD histogram at 0.0000 suggests bearish momentum, creating conflicting signals for traders.

The Bollinger Bands analysis reveals APT trading near the middle band at $0.93, with the upper band at $1.05 representing immediate resistance and the lower band at $0.81 providing downside protection. The %B position at 0.5250 confirms APT is trading slightly above the middle of its recent range.

Moving averages paint a concerning longer-term picture. While the 20-day SMA at $0.93 aligns with current prices, the 50-day SMA at $1.14 and 200-day SMA at $2.63 highlight the significant decline from previous highs. The EMA 12 at $0.95 and EMA 26 at $1.00 suggest short-term resistance levels that align with analyst predictions.

Key trading levels show immediate resistance at $0.96 and strong resistance at $0.98, while support levels sit at $0.91 and $0.90. The daily ATR of $0.09 indicates moderate volatility, typical for current market conditions.

Aptos Price Targets: Bull vs Bear Case Bullish Scenario The optimistic Aptos forecast targets the $1.05-$1.24 range, requiring a breakout above the immediate resistance at $0.98. Technical confirmation would come from RSI moving above 50 and MACD turning positive. The Bollinger Band upper limit at $1.05 represents the first major target, with extension to $1.24 possible if momentum builds.

Volume expansion above the current 24-hour average of $3.2 million would support this bullish thesis. A sustained break above the EMA 26 at $1.00 could trigger algorithmic buying, pushing APT toward the analyst targets.

Bearish Scenario The downside risk centers around the critical support at $0.90. A break below this level could trigger stops and push APT toward the Bollinger Band lower limit at $0.81. The weak MACD momentum and position below longer-term moving averages support this bearish possibility.

If selling pressure intensifies, APT could test the psychological $0.80 level, representing approximately 14% downside from current prices. The 50-day SMA at $1.14 remains far overhead, acting as dynamic resistance.

Should You Buy APT? Entry Strategy For this APT price prediction scenario, consider accumulating on dips toward the $0.90-$0.91 support zone. This level offers favorable risk-reward with stops placed at $0.88, limiting downside to approximately 4%.

Target the first resistance at $0.96-$0.98 for partial profit-taking, then hold remaining positions for the analyst targets of $1.05-$1.24. This strategy provides multiple exit opportunities while maintaining exposure to potential upside.

Risk management remains crucial given the mixed technical signals. Position sizing should reflect the uncertain momentum environment, with larger positions reserved for clear breakout confirmation above $0.98.

Conclusion This APT price prediction suggests cautious optimism is warranted despite current technical headwinds. The convergence of analyst targets around $1.05-$1.24 provides compelling upside potential, representing 13-33% gains from current levels.

However, the bearish MACD and position below key moving averages require careful risk management. The neutral RSI offers room for upward movement, but confirmation through volume and momentum indicators remains essential.

Disclaimer: Cryptocurrency investments carry significant risk. This analysis is for educational purposes only and should not be considered financial advice. Always conduct your own research and consider your risk tolerance before making investment decisions.

Image source: Shutterstock

apt price analysis apt price prediction

Terrill Dicki Mar 08, 2026 19:11

ARB price prediction shows potential 20-40% upside to $0.12-0.14 range within 6-8 weeks as technical indicators suggest oversold bounce despite current bearish momentum.

ARB Price Prediction Summary • Short-term target (1 week): $0.095-$0.105 • Medium-term forecast (1 month): $0.12-$0.14 range
• Bullish breakout level: $0.11 • Critical support: $0.09

What Crypto Analysts Are Saying About Arbitrum Recent sentiment from crypto Twitter shows mixed but cautiously optimistic views on ARB. Lucky Predictor (@20Floki20) recently identified "$ARB" as one of the "Gems to Watch in this Bull Run" alongside other altcoins, suggesting growing attention from the crypto community despite current price weakness.

Earlier analyst predictions from January 2026 provided more specific targets. Tony Kim projected ARB could reach $0.25 within 3-4 weeks based on bullish MACD momentum, while James Ding suggested potential gains of 14-27% to the $0.25-$0.28 range. Darius Baruo similarly forecasted targets of $0.26-$0.28 within four weeks, though these predictions were made when ARB was trading around $0.21.

According to on-chain data from major analytics platforms, Arbitrum's network fundamentals remain solid despite the recent price decline, with consistent transaction volumes and developer activity supporting longer-term bullish sentiment.

ARB Technical Analysis Breakdown Current technical indicators present a mixed picture for this ARB price prediction. Trading at $0.10, ARB has declined 1.54% in the past 24 hours with a trading range between $0.094-$0.097.

The RSI reading of 33.13 indicates ARB is approaching oversold territory, suggesting potential for a technical bounce. However, the MACD histogram at 0.0000 shows bearish momentum has stalled rather than reversed, indicating consolidation rather than immediate bullish momentum.

ARB's position within the Bollinger Bands at 0.27 (where 0 represents the lower band) shows the token is trading in the lower portion of its recent range. The middle band at $0.10 aligns with current resistance, while the upper band at $0.11 represents the first major breakout target.

Moving averages paint a concerning picture for short-term momentum. The 200-day SMA at $0.27 sits significantly above current levels, indicating a strong long-term downtrend. However, shorter-term averages (7-day and 20-day SMA) both at $0.10 suggest consolidation around current levels.

Arbitrum Price Targets: Bull vs Bear Case Bullish Scenario In the optimistic case for this Arbitrum forecast, ARB could target the upper Bollinger Band at $0.11 as the first resistance level. A break above this level could open the path toward $0.12-$0.14, representing the 50-day SMA region around $0.13.

Key technical confirmation would include RSI breaking above 40, MACD histogram turning positive, and daily volume exceeding the current $3.3 million average. The bullish case aligns with broader altcoin recovery patterns and Arbitrum's strong ecosystem fundamentals.

Bearish Scenario The bearish case sees ARB testing the lower Bollinger Band around $0.09, which aligns with immediate support levels. A breakdown below this level could target $0.08 or potentially $0.075, representing a continuation of the longer-term downtrend.

Risk factors include broader crypto market weakness, Ethereum scaling competition, and the significant gap between current price and longer-term moving averages. The 200-day SMA at $0.27 represents the massive resistance that would need to be overcome for any sustained bull run.

Should You Buy ARB? Entry Strategy For this ARB price prediction strategy, consider dollar-cost averaging around current levels of $0.095-$0.105. The oversold RSI suggests limited downside risk in the immediate term, while the consolidation pattern indicates accumulation opportunities.

A more aggressive entry could wait for a break above $0.11 with increased volume, confirming the bullish breakout scenario. Conservative investors might prefer waiting for RSI to reach oversold levels below 30 before initiating positions.

Stop-loss levels should be placed below $0.09 to limit downside risk. Risk management suggests position sizing of no more than 2-3% of portfolio given the high volatility indicated by the daily ATR of $0.01.

Conclusion This ARB price prediction suggests moderate upside potential to $0.12-$0.14 over the next 6-8 weeks, representing 20-40% gains from current levels. The technical setup shows oversold conditions that could support a bounce, though broader trend remains bearish.

The Arbitrum forecast carries medium confidence given mixed technical signals and the significant distance from longer-term moving averages. Investors should approach with appropriate risk management and consider ARB as a higher-risk recovery play rather than a stable growth investment.

Disclaimer: Cryptocurrency price predictions are highly speculative and subject to extreme volatility. This analysis is for educational purposes only and should not be considered financial advice. Always conduct your own research and never invest more than you can afford to lose.

Image source: Shutterstock

arb price analysis arb price prediction

Recent on-chain data provided by analytics boutique Glassnode has revealed that a massive swath of the network is currently underwater.

According to the latest metrics released by blockchain intelligence firm Glassnode, approximately 36.8 billion XRP tokens are currently held at a loss. This represents an eye-popping $50.8 billion in unrealized losses across the XRP ecosystem.

XRP's topsy-turvy ride An "unrealized loss" occurs when the current market price of an asset drops below the original acquisition price of the tokens held in a specific wallet. 

HOT Stories

Throughout 2025, XRP's price (the black line) experienced a headline-grabbing parabolic run. The Ripple-linked token soared past the $1, $2, and eventually breached the $3 level, setting a new record high. 

During this euphoric peak, the grey area virtually vanished, dropping close to zero. At the height of the 2025 bull run, nearly every single XRP token in circulation was holding unrealized profits.

You Might Also Like

Then, however, XRP nose-dived back toward the $1 to $2 range. The grey "Supply in Loss" has experienced an upward surge, eventually reaching the current 36.8 billion XRP level. 

This current spike in unprofitable supply is approaching historical "max pain" thresholds in line with previous bear markets. 

It remains to be seen whether or not these trapped buyers will hold out for a macro reversal. One should not rule out a new wave of capitulation selling. 

After a brief relief rally in January, XRP succumbed to heavy sell-side pressure. The price sliced through multiple psychological support levels with minimal bounce.  Since that massive February drop, XRP has so far failed to pull off any meaningful relief rally.  The price is currently hovering precariously near the bottom of this consolidation range, changing hands at $1.34, CoinGecko data shows. 

Journalist

Posted: March 9, 2026

Over the past week, Bitcoin [BTC] challenged the $74k resistance but failed to break above it. Bears then forced an 8.9% retracement from the local highs within four days.

This short-term volatility triggered sharp moves across several medium-cap altcoins.

OKB rallies beyond $100 after investment announcement

Source: OKB/USDT on TradingView

Intercontinental Exchange, the parent company of the New York Stock Exchange, acquired a minority stake in the OKX exchange. The deal saw the exchange receive a $25 billion valuation, although the exact investment figures were unknown.

This saw the OKB token prices rally from $77 to $120 within a day.

Additionally, the rally originated from around the $79 level, a key long-term support.

Long-term investors would want to see the $120 level, which has served as resistance since mid-November 2025, to be flipped to support before buying.

Pi Network token shrugs off bull trap fears AMBCrypto had reported that the PI long-term trend was bearish. The $0.207 level was a key swing level, with the $0.215 also being a supply zone from December 2025 for buyers to beware of.

The triangle pattern saw a firm bullish breakout, breaching both resistances and flipping the long-term bias bullishly.

Traders and investors can wait for a retracement to look for buying opportunities.

Other notable winners Memecore [M] was able to challenge the mid-range resistance at $1.57, noting a 9.2% rally compared to last Sunday’s low.

However, in recent hours of trading, it was forced to fall to the $1.5 level yet again. Traders could keep an eye on this memecoin and its mid-range resistance.

Mantle [MNT] was another altcoin to keep an eye on.

It has posted a 5.73% gain over the past week and has breached the local swing point at $0.68.

Weekly losers Cardano faces renewed “ghost chain” criticism

Source: ADA/USDT on TradingView

Despite being a large-cap crypto asset, the Cardano [ADA] blockchain has faced criticism for low onchain activity for years.

This viewpoint surfaced once again as popular analyst Ali Martinez drew attention to the chain’s low activity and slow pace of development.

The analyst also observed that the chain’s Total Value Locked has never exceeded $1 billion.

For reference, industry leader Ethereum [ETH] boasted a $54.67 billion TVL at the time of writing.

On the price charts, ADA has shed 9.61% from last Sunday’s open at $0.281. The stiff resistance at $0.305 was not overcome, but a test of the $0.246 support zone could be interesting.

WLFI team dumps $1.74 million worth of tokens World Liberty Financial [WLFI] has fallen 14% since last Sunday’s open, i.e., on the 8th of March.

AMBCrypto reported that the token could fall by 25% to $0.07 if the $0.097 support is not defended. At the time of writing, WLFI was trading at $0.0968.

Other notable losers ZCash [ZEC] was down 10.4% from last week. It has made the losers’ list twice in a row now. The $187 support level was a key long-term retracement level that bulls will likely fight to defend.

Solana [SOL] tested the $90 supply zone but was unable to break through. Its onchain metrics signaled seller pressure was imminent, which could lead to further drawdown.

More losses to accompany the start of the next week Bitcoin was falling toward the $63k-$65k demand zone, where the previous bullish impulse move originated.

The retracement and a subsequent bullish reaction could give certain altcoins the push to climb higher next week.

Volatility is expected to continue, and traders should wait for BTC to set the tone for next week’s trends.

Final Summary OKB and Pi Network tokens grabbed the limelight with a strong bullish showing over the past week. Cardano and Solana were popular large-cap coins that were unable to scale local supply zones recently. Disclaimer: The information presented does not constitute financial, investment, trading, or other types of advice and is solely the writer’s opinion.

Countless investors rely on exchange-traded funds to get the stock market exposure they want and need. For those seeking to track a market index composed of hundreds of stocks, it would be impractical to try to buy every single individual stock in the index and track it in your portfolio. ETFs made the job a lot easier, as the fund manager takes care of all that buying and selling for you. All you need to do is invest in shares of the ETF, pay a modest annual expense ratio, and earn the returns of whatever benchmark the fund has chosen to follow.

However, one key question that investors have to answer is just how much exposure to stocks they want. In order to diversify your portfolio properly, it's important to have a fund that owns more than just a few different stocks. Yet even if you do own a fund with hundreds of different holdings, you still have to ask yourself whether that ETF actually gives you complete exposure to all the different types of companies you want.

One Vanguard ETF took a step back and saw what many of its rivals' ETFs were concentrating their efforts on for investors. It chose to go a step further, and it has made all the difference for its shareholders. In this three-part series for the Voyager Portfolio, you'll learn more about the Vanguard Total Stock Market ETF (VTI 1.37%) and how one simple decision marked a revolutionary change for the industry.

Image source: Getty Images.

It's easy to invest in proven winners During March, the Voyager Portfolio has looked at two giants of the ETF industry. The SPDR S&P 500 ETF (SPY 1.22%) was the first ETF to list shares on U.S. markets. The Invesco QQQ ETF (QQQ 1.50%) concentrated on the particular subset of companies that happened to list on the Nasdaq stock market.

Both of these funds have something in common. Their goal is to track indexes that exclusively hold large-cap stocks. And indeed, when you look at their holdings, you'll notice that a huge percentage of their assets go toward buying just a handful of stocks. Most of those stocks are the tech leaders that have grown their way to market capitalizations of $1 trillion or more.

Owning large-cap stocks has been a great way for investors to earn strong returns to help reach their financial goals. But it's not the only way. Indeed, historically, stocks of companies that haven't yet achieved large-cap status have on average performed even better than large-caps. That means that there's a huge gap in the coverage of the stock market that owners of the SPDR S&P 500 ETF or Invesco QQQ ETF need to fill if they want to have a truly diversified portfolio.

Looking beyond the stocks you already know The Vanguard Total Stock Market ETF chose to adopt a strategy that was more inclusive than its peers. Rather than investing solely in large-cap stocks, it chose to track an index that covers a much wider swath of the stock market. The CRSP U.S. Total Market Index was designed to represent 100% of the investable equity market for U.S. stocks.

As a result, the Vanguard Total Stock Market ETF looks a lot different from its big-league peers. It owns roughly 3,500 stocks. The average market capitalization for each company is $19.5 billion, but half of the stocks in the index have market caps of less than $1.311 billion. It even includes companies with market caps as small as $4 million.

Today's Change

(

-1.37

%) $

-4.59

Current Price

$

331.41

To be clear, Vanguard Total Stock Market ETF doesn't go overboard with its spicing of smaller companies. You'll still get over 70% of your money invested in large-cap companies. But about 20% of the portfolio goes toward mid-cap stocks. Another 6% gives you some small-cap exposure, and roughly 2% of the money you invest gets spent buying shares of true micro-cap stocks.

Having more diversification is great, but has it led to better performance for its shareholders? The next article in this series on the Vanguard Total Stock Market ETF looks more closely at this question.

Perhaps the biggest surprise in Amazon's (AMZN 2.61%) latest results was the additional $200 billion it plans to spend -- mostly on Amazon Web Services (AWS) -- this year. That figure blew well past analyst expectations and shows just how much Amazon and companies like it are betting on AI.

It's really no wonder why. AWS was far and away Amazon's fastest-growing revenue stream as of its latest quarter, with sales up 24% year over year for the 2025 fourth quarter.

While Amazon does design some of its hardware in-house, even Jeff Bezos' brainchild doesn't have all the money and expertise it needs to create its own AI hardware ecosystem. And, like most other companies involved in the AI industry, Amazon needs to work with Nvidia (NVDA 2.94%) to bring its goals to fruition.

So, I expect Nvidia will be one of, if not the biggest beneficiary of Amazon's $200 billion investment.

Image source: Getty Images.

With a little help from its friends Nvidia doesn't need much in the way of an introduction. The company was probably the biggest stock market story in 2025, especially when it broke out above $5 trillion in valuation late last year.

Its graphics processing units (GPUs) are the preferred hardware for all the most advanced AI programs out there. And while Nvidia is facing some competition now, namely from Alphabet's (GOOG 0.87%) Tensor Processing Units (TPUs), it remains the dominant AI hardware player with about 92% market share.

Amazon and Nvidia have a rather cozy relationship stretching back 15 years, and it seems to be a mutually beneficial one. AWS' AI infrastructure runs on Nvidia hardware, and the two companies have heavily integrated their technology.

In December of last year, Amazon and Nvidia expanded their partnership with AWS, adding support for Nvidia's NVLink Fusion AI infrastructure. Amazon also plans for its Trainium4 chip to integrate and play nice with Nvidia's products.

The partnership expansion includes the integration of Nvidia's software into AWS' AI suite, meaning AWS developers will be able to build their own Nvidia-based AI programs and agents.

In short, the two companies are heavily integrated, and with Amazon spending so much on AI, you can bet Nvidia will absorb a good chunk of that cash, though Nvidia was hardly hurting before Amazon's planned spending surge.

Today's Change

(

-2.94

%) $

-5.39

Current Price

$

177.95

Still king of the road Despite strong results recently, Nvidia stock dipped after its recent earnings report as investors expressed some concern about the future. But I view this as an opportunity to buy shares before Nvidia's next growth cycle.

For Q4 2025, Nvidia saw its revenue hit $68.1 billion, up 73% over Q4 2024. Over the same period, it grew its gross margin 2 points to 75%, its net income 94% to $42.96 billion, and its diluted earnings per share (EPS) 98% to $1.76.

The full-year 2025 numbers were also incredible. Revenue for the year hit $215.9 billion, a 65% increase year over year; operating income and net income both grew 58% over 2024; and diluted EPS for 2025 came in at $4.77, up 60% over the previous year.

It is worth noting that for the full year, Nvidia's gross margin fell 3.9 points to 71.3%, but that seems to be the only hiccup in an otherwise stellar earnings report. Also, while its gross margin fell, Nvidia's operating and net margins remained stable at 60.38% and 55.6%, respectively, so it is still exceedingly profitable.

Nvidia also maintains a very healthy balance sheet with cash reserves standing at $62.5 billion at the end of its fiscal 2025, up 44% over 2024 and comfortably higher than the company's liabilities of $49.5 billion.

Finally, Nvidia's operating cash flow grew 60% to $102.7 billion for 2025, so it's not hurting for money to continue expanding its business, to say the very least, nor is it heavily indebted.

Add all that together, and I think you've got a winner on your hands or rather a continued winner in Nvidia's case, as the stock is up 50% over the past year. Nvidia is still going strong, and Amazon's AI spending surge is set to keep the growth coming.

GLP-1 drugs are all the rage on Wall Street today, with demand for these weight loss products expected to be strong for years to come. That's helped to supercharge Eli Lilly's (LLY +0.72%) growth and its stock price. However, you might be better off with this higher-yielding drug peer, even though it doesn't compete in the GLP-1 market.

Image source: Getty Images.

Too much of a good thing Eli Lilly was second to market with a GLP-1 drug, but Mounjaro and Zepbound proved to be more effective than competing products. They are now the leading GLP-1 drugs, with 2025 revenue growth of 99% and 175%, respectively. Together, they account for 56% of Eli Lilly's top line. Eli Lilly has a lot riding on the success of these two drugs.

Wall Street isn't focusing on that risk; it has pushed Eli Lilly's stock price sharply higher. The price-to-earnings (P/E) ratio is 44, and the dividend yield is a miserly 0.6%. It looks like Eli Lilly is priced for perfection. If you have a value bias or prefer more income, you'll probably want to look elsewhere.

Today's Change

(

0.72

%) $

7.07

Current Price

$

990.33

Merck operates in different places Merck (MRK 0.17%) doesn't compete with Eli Lilly in the GLP-1 space. Merck is focused on treating cancer, infections, and cardiometabolic disease. These areas may not be as exciting as weight loss right now, but they are very important therapeutic categories. And while Merck has some patent expirations coming up, it also has a strong pipeline of new drugs.

Meanwhile, the big patent expiration for Keytruda in the U.S. market may not be as bad as it seems. Merck has international patents for the drug that extend into the early 2030s. It also has a new Keytruda delivery method that could extend patent protection into the late 2030s.

Today's Change

(

-0.17

%) $

-0.20

Current Price

$

115.87

That said, the real reason to prefer Merck over Eli Lilly is a mixture of valuation and yield. Merck's P/E ratio is a far more reasonable 16, and its yield is a dramatically higher 2.8%. Merck also has a long history of supporting its dividend, which hasn't been increased every year but has moved steadily higher for over three decades. And with a payout ratio of roughly 50%, there seems to be little risk that a cut would take place at this juncture.

Eli Lilly isn't bad, just expensive There's nothing wrong with Eli Lilly, per se. It is doing very well as a business right now. However, Wall Street has placed a very rich valuation on the stock. If you are looking for a dividend-paying pharmaceutical giant, Merck will probably be more to your liking.

March 08, 2026 14:00 ET  | Source: Xenon Pharmaceuticals Inc.

VANCOUVER, British Columbia and BOSTON, March 08, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and commercialization of life-changing therapeutics for patients in need, will announce topline data from the Phase 3 X-TOLE2 study of azetukalner, a novel, potent KV7 potassium channel opener, in patients with focal onset seizures (FOS), on Monday, March 9, 2026.

Conference Call/Webcast Information:  Date:Monday, March 9, 2026  Time:8:00 am ET (5:00 am PT)  Webcast:Pre-register here  Dial-In:(800) 715-9871 toll-free or (646) 307-1963 for international callers
  Conference ID:7885306   A live webcast of the company presentation will be available on the Investors section of Xenon's website and posted for replay following the event. The above listed dates and times are subject to change.

About Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals (Nasdaq: XENE) is a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and commercialization of life-changing therapeutics for patients in need. Xenon’s lead molecule, azetukalner, is a novel, potent KV7 potassium channel opener in Phase 3 clinical trials for the treatment of epilepsy, major depressive disorder (MDD) and bipolar depression (BPD). Xenon is also advancing an early-stage portfolio of multiple promising potassium and sodium channel modulators, including KV7 and NaV1.7 programs in Phase 1 development for the potential treatment of pain. Xenon has offices in Vancouver, British Columbia, and Boston, Massachusetts. For more information, visit www.xenon-pharma.com and follow us on LinkedIn and X.

Xenon and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in the US, Canada, and elsewhere. All other trademarks belong to their respective owner.

Contacts

For Investors:
Tucker Kelly
Chief Financial Officer
[email protected]

For Media:
Colleen Alabiso
Senior Vice President, Corporate Affairs
[email protected]

47.01K Followers

Analyst’s Disclosure: I/we have a beneficial long position in the shares of CRM, NOW either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Plug Power (PLUG 7.21%) published its fourth-quarter and full-year results on March 2, and the contents of the report have powered big gains for the company's stock. Sales for the year increased 12.9% on an annual basis to come in at $709.9 million, beating the average analyst estimate by approximately $7.9 million. The business also shifted into posting a positive gross profit of $5.5 million in the fourth quarter -- coming in at 2.4% of revenue for the period.

Plug Power is a specialized provider of hydrogen fuel cells, elctrolyzers, transportation services, and related technologies that went public in 1999. The company's progression of commercial scaling has frequently fallen short of expectations since going public, and management has relied on new share offerings to fund business operations. As a result, the stock is down roughly 98.5% since market close on the day of its initial public offering (IPO). Has Plug Power reached a turnaround point that could eventually turn the stock into an income-generating machine?

Image source: Getty Images.

Long-term shareholders could be a looking at a binary outcome When it comes to the outlook for Plug Power stock over the next 25 years, investors are probably looking at a binary outcome. If the business is still in operation as a stand-alone entity and the stock has started paying a dividend, it's virtually certain that the company's share price will have seen massive capital appreciation. Along those lines, strong performance for the business will have likely put the company in a position where it can return cash to shareholders through substantial dividend payments at regular intervals.

On the other hand, the business still recorded a net loss of $1.69 billion. While that performance represented a significant improvement over the $2.1 billion loss it posted in 2024, the viability of the company's pathway to profitability is still highly uncertain.

The other side of this binary dynamic is that Plug Power still faces substantial risks of going bankrupt at some point over the next 25 years. In that scenario, investors would likely see most or all of the value of their position wiped out.

Today's Change

(

-7.21

%) $

-0.17

Current Price

$

2.13

In order for paying regular dividends to be sensible, Plug Power will almost certainly have to have reached a point where it's reliably generating positive earnings and free cash flow. If such a scenario were to pan out, investors who take a buy-and-hold approach to the stock over the next 25 years will likely be generating substantial income on their holdings after years of dividend growth. Gains on the stock could also be life-changing depending on the principle amount invested in that scenario.

Of course, investors should move forward with the understanding that such an outcome is anything but certain. Plug Power still has a long way to go before it shifts into generating positive cash flows, and there's a lot that could still go wrong over the next 25 years.

Keith Noonan has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

© MCCAIG / iStock via Getty Images

Hedge funds and institutional investors have been quietly building positions in Meta Platforms (NASDAQ:META | META Price Prediction) despite recent market volatility, viewing it as one of the most compelling opportunities in the AI and digital advertising space. With its massive user base, dominant ad business, and aggressive push into generative AI, Meta has attracted significant buying interest from sophisticated money managers who see the stock trading at a discounted valuation relative to its long-term growth potential. 

In recent quarters, multiple high-profile funds have added to or initiated stakes, reflecting broad confidence that near-term concerns are overblown and that Meta is positioning itself as a foundational player in the next wave of technology. This institutional accumulation highlights the growing consensus that Meta offers asymmetric upside in a market hungry for proven AI exposure.

Investor Fears Over AI Spending Meta’s decline stems largely from Wall Street’s unease over the company’s aggressive AI buildout. It guided 2026 capital expenditures to a staggering $115 billion to $135 billion — nearly double 2025 levels — primarily for data centers, GPUs, and AI infrastructure. Investors worry this spending spree will compress margins in the near term, especially if returns from new AI products lag.

Despite robust fundamentals — advertising revenue grew 24% in Q4 to nearly $60 billion, driven by Reels and AI-powered ad tools — short-term execution risks have overshadowed the story. Meta’s stock pulled back sharply after prior earnings as capex guidance rose, reflecting broader concerns that the social media giant is over-investing without immediate payoff. Yet this pullback created the very entry point that caught Ackman’s eye.

Wall Street’s Optimistic Forecast Analysts remain overwhelmingly bullish. The consensus 12-month price target sits at $844, implying roughly 31% upside from current levels, with 42 out of 49 analysts issuing Buy ratings.

Their confidence stems from Meta’s core advertising machine remains unmatched, powering double-digit revenue growth even as AI enhancements boost engagement and ad efficiency. Open-source Llama models are gaining traction, positioning Meta as a leader in accessible AI. 

Analysts project continued margin expansion long-term as AI monetization scales through targeted ads, creator tools, and potential new revenue streams like AI agents and smart glasses. The stock’s forward P/E of around 18x looks attractive relative to growth prospects, especially compared with pricier AI peers. Wall Street forecasts 19% annual EPS growth over the next five years.

Strengthening AI Infrastructure Meta is not betting blindly. In February, the company expanded its partnership with Nvidia (NASDAQ:NVDA), securing millions of current- and next-generation GPUs plus Vera Rubin rack-scale systems for its data centers. To diversify beyond Nvidia and mitigate supply risks, Meta also signed a multi-billion-dollar, multi-year deal to rent Google’s Tensor Processing Units (TPUs). This move reduces dependency on a single supplier while accelerating model training for Llama and other AI initiatives.

These alliances signal disciplined execution: Meta is building one of the largest AI infrastructures globally while hedging costs and timelines. Combined with its massive base of nearly 4 billion active monthly users, the setup positions Meta to translate heavy investment into a sustainable competitive advantage.

Key Takeaway Despite Meta Platforms’ solidifying position as an AI powerhouse — evident in cutting-edge models, ad platform enhancements, and strategic chip partnerships — its ballooning capex puts it at risk of margin pressure if AI monetization lags. Depreciation, talent costs, and infrastructure operating expenses could weigh on profitability through 2026 and beyond.

That said, its AI bets clearly outweigh the risks. The company’s proven advertising engine generates the cash flow to fund this transformation without debt strain, while early AI wins already show up in engagement metrics and efficiency gains. With Wall Street projecting strong earnings growth and analysts’ high-conviction stake validating the thesis, Meta stands as a compelling long-term winner. Investors who look past near-term noise will likely be rewarded as AI delivers the next leg of hyper-growth.

Small Cap write on sticky notes isolated on Office Desk. Stock market concept

getty

What’s better than getting to buy 6.6%-11% yields at discounted prices?

How about snapping those sweet dividend payers while momentum is on your side?

Late in 2025, I wrote about a “small-cap reawakening”—a bullish tailwind from retreating Federal Reserve rates that had begun to propel smaller companies forward and could continue well into 2026.

So far, so true. Small- and mid-cap stocks (or “SMIDs”) alike have been cruising full sail ahead while their larger cousins have been dead in the water.

SMID Total Returns

Ycharts

Better still for you if you haven’t yet taken the plunge into Wall Street’s more diminutive stocks: Small caps’ hot start has done little to drive up valuations. They still look like a screaming bargain compared to the market’s bigger names:

Broad-Market Forward P/Es:

S&P 500: 21.2S&P MidCap 400: 17.0S&P SmallCap 600: 15.6Fair warning: Economic turbulence is almost always tougher on smaller-cap equities, so we could always be a market scare away from a flight back into large caps.

MORE FOR YOU

The fuel driving smaller companies could run out in a few months, too. The Fed declined to move its target interest rate lower in late January, and the market is betting we don’t see another step lower until summer at the soonest.

But we’re all aware that a step into small caps means swallowing at least a spoonful of risk. Our best bet? Find the most advantageously positioned small caps… and get paid a truckload while we hold on for the ride.

Which is exactly what I see in these five small caps paying us between 6.6% and 11.0% right now.

High Yield Small Cap #1: Washington Trust Bancorp (WASH)Financial firms as a group don’t deliver much more income than the broader market, but you can find some downright respectable yields in the sector’s smaller names: specifically, regional banks and credit unions.

Washington Trust Bancorp. (WASH), for instance, currently pays more than 6%.

This 225-year-old regional bank is neither in Washington, D.C., nor Washington State. Instead, it was named for the nation’s first president, and it proudly claims that it was “the first bank to print George Washington’s likeness on currency—69 years before President Washington appeared on the federally issued one-dollar bill and 132 years before the Washington quarter appeared.”

The operations are typical bank fare: personal and business banking offerings such as checking, savings, mortgages, financing and wealth management. The stock really hasn’t been noteworthy, either, delivering subpar performance relative to both the market and the financial sector for quite some time. WASH shares were barely above breakeven in 2025—and that’s only once we include its sizable dividend!—following a balance sheet repositioning near the end of 2024.

But Washington Trust is alive and well in 2026. In January, the company’s Street-beating results were helped by net interest margins that improved by 16 basis points YoY for the fourth quarter, and by 53 basis points YoY for the full year. The news sparked one of the biggest moves in WASH stock in years. Meanwhile, shares still trade for just 10 times earnings that are expected to jump by 27% in 2026 and offer one of the best yields in banking.

High Yield Small Cap #2: Diversified Energy Company (DEC)When we think of “integrated” energy companies, we typically think of mega-cap titans like Exxon Mobil (XOM) and Chevron (CVX). But $1 billion Diversified Energy Company (DEC) checks off the right boxes, too.

It produces predominantly natural gas, but also some oil and natural gas liquids (NGLs), from the Appalachian (70% of production) and Central (30% of production) regions of the U.S. It also has about 17,000 miles of gathering and transportation lines, as well as compression stations, and it’s a top-25 North American gas marketer. It even has a well retirement service arm: Next LVL Energy.

It’s an odd stock with an odd history. The company started in the U.S. back in 2001, but it didn’t list publicly until 2017—on the London Stock Exchange. It only began trading in the U.S. in 2023, when it launched a secondary listing on the New York Stock Exchange; those NYSE shares became the company’s primary listing in 2025. Shares have delivered all the excitement of a small-cap company since then.

DEC Total Returns

Ycharts

That largely reflects the Diversified model—rather than undergoing capital-intensive drilling and development programs that can make splashy discoveries, DEC instead acquires long-life assets and tries to squeeze as much life out of them as possible.

Last year was no exception. The company completed the acquisition of “liquids-rich” Maverick Natural Resources in March 2025, then closed on a purchase of Oklahoma-based oil-and-gas E&P firm Canvas in November. The buying has continued this year; DEC recently announced it was buying natural gas properties in east Texas from Sheridan Production.

There’s admittedly not much room for breakneck growth in this model. But it does adequately fund a generous dividend yielding 8% right now, on a stock that trades at less than 8 times this year’s earnings estimates.

High Yield Small Cap #3: Granite Ridge Resources (GRNT)Granite Ridge Resources (GRNT) is another energy name with an unorthodox business model. It says it “combines the agility of an investment firm with the expertise of an energy company.” In practice, it doesn’t operate anything—it simply holds oil and gas assets in the Permian, Eagle Ford, Bakken, Haynesville, DJ and Appalachian formations.

It’s almost fitting, then, that the company didn’t go public via a traditional IPO, but via special purpose acquisition company (SPAC). Investment firm Grey Rock Investment Partners merged in October 2022 with Executive Network Partnering Corporation (the SPAC).

GRNT hit the market with a thud, dropping like a rock over the first few months. Since then, it has delivered roughly breakeven returns (and that’s after factoring in the 8%+ dividend), which is right in line with its nonexistent dividend growth.

However, like DEC, Granite Ridge might have been building toward something in 2025, with the company projecting 28% production growth for the full year. That should allow the company and its roughly 3,200 wells to take better advantage of any improvements in price.

But unlike other small energy names, Granite Ridge appears to be a primarily steady cash flow and dividend producer first, and a growth prospect second.

High Yield Small Cap #4: Perrigo (PRGO)Perrigo (PRGO) is an over-the-counter health and wellness company with a wide range of products we’re all used to seeing on Walgreens and CVS shelves: sinus and allergy relief, antacids, sleep aids, pain relievers, toothbrushes, skin care, vitamins, contraceptives and more.

It’s also a long, long, long way removed from its heyday of roughly a decade ago.

In 2015, Perrigo was a large cap on the rise—so much so that it attracted the advances of global generics specialist Mylan. PRGO rebuffed Mylan several times, most notably in April 2015 when it turned down a $205-per-share offer, then a $232-per-share offer shortly thereafter. Perrigo’s board, then its shareholders, turned back a hostile bid later in the year.

PRGO Total Returns

Ycharts

The top and bottom lines have stagnated or declined in most years since 2015. Generics margins suffered amid growing competition, and FDA approvals tapered off. The company has since undergone multiple restructuring plans and pivoted to lean harder into self-care products. But it’s still sliding; during its Q4 2025 report, it said sales would be down 1.5% to 5.5% in 2026, and adjusted diluted earnings per share would fall by 16% to 27%.

A few days earlier, it also announced that it would keep its dividend level—maybe not surprising given its continued weakness, but perhaps another warning sign given that PRGO is currently riding a 22-year streak of annual dividend growth.

Perrigo is very much a stock to watch just given the potential to pick up a double-digit yielder on the cheap—it currently trades at a skinny 5 times 2026 earnings estimates. But we need to see some signs of operational stabilization first; otherwise, this small cap will just keep getting smaller.

High Yield Small Cap #5: Insperity (NSP)Insperity (NSP) is a human resources (HR) and business solutions provider to small- and medium-sized businesses. That’s payroll, benefits, HR, employee onboarding, time and attendance, performance and more, provided through multiple Insperity-branded platforms.

This is a name that has only recently started to ping my high-yield radar, which usually means one of two things has happened:

A massive dividend increase, say, double or more (rare)The stock has plunged into the earth’s core (common)NSP Total Returns

Ycharts

The stock is unsurprisingly cheap as a result, trading at 10 times this year’s earnings estimates.

The question is whether NSP is a generational value play or a falling knife.

The plunge was due to a complete erosion of Insperity’s bottom line, as well as sentiment for both small- and midsized businesses and the labor market. The company earned $171.4 million in 2023, then $91 million in 2024, then suffered a $7 million net loss in 2025. Health care costs have been a major factor here, chewing into Insperity’s margins.

But the top line hasn’t flinched. Revenues have climbed in all but one year over the past decade, and they’re expected to keep rising by single digits in each of the next two years. A renegotiated contract with UnitedHealth Group (UNH) could relieve some of its cost pressures. And there’s potential in its new Insperity HRScale—an HR platform built in partnership with Workday (WDAY) that promises “faster deployment and simpler setup” and that the company expects will host 6,000 to 8,000 paid worksite employees (WSEEs) by year’s end.

It might be enough for a turnaround, but even if it is, we have to consider whether the dividend will still be there. The $2.40 per share that Insperity pays across the year was more than twice NSP’s adjusted earnings in 2025, and it’s projected to overshoot 2026 profits, too.

Brett Owens is Chief Investment Strategist for Contrarian Outlook. For more great income ideas, get your free copy his latest special report: How to Live off Huge Monthly Dividends (up to 8.2%) — Practically Forever.

Oklo (OKLO 6.08%) is navigating the tension between explosive AI-driven power demand and the slow reality of nuclear licensing. I break down why new-customer backing matters, what execution risks remain, and how long-term upside depends on milestones that most investors are not yet fully pricing in.

Stock prices used were the market prices of March 2, 2026. The video was published on March 7, 2026.

Rick Orford has positions in Meta Platforms. The Motley Fool has positions in and recommends Meta Platforms. The Motley Fool has a disclosure policy. Rick Orford is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through their link, they will earn some extra money that supports their channel. Their opinions remain their own and are unaffected by The Motley Fool.

NEW YORK, March 08, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Ardent Health, Inc. (NYSE: ARDT) and certain of its officers.

This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Ardent securities between July 18, 2024 and November 12, 2025, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: bgandg.com/ARDT.

Ardent Case Details

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that:

(1) Ardent Health’s third quarter 2025 revenue was overstated due to inadequate determinations of accounts receivable collectability following the Company’s transition to a new revenue accounting system and “recently completed hindsight evaluations of historical collection trends”; 
(2) the Company’s 2025 EBITDA guidance was overstated and would be reduced by $57.5 million at the midpoint, or approximately 9.6%, due to “persistent industry-wide cost pressures,” including “payer denials”; and 
(3) as a result, Defendants’ statements about the Company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

What's Next for Ardent Investors?

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: bgandg.com/ARDT. or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in Ardent you have until March 9, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.

No Cost to Ardent Investors

We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman, LLC for Ardent Securities Class Action?

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com

"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.

Follow us for updates on LinkedIn, X, Facebook, or Instagram.

Contact Info

Peretz Bronstein, Esq. or Nathan Miller
Bronstein, Gewirtz & Grossman, LLC
917-590-0911 | [email protected]

Attorney advertising.
Prior results do not guarantee similar outcomes.

NEW YORK, March 08, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against BellRing Brands, Inc. (NYSE: BRBR) and certain of its officers.

This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired BellRing securities between November 19, 2024 and August 4, 2025, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: bgandg.com/BRBR.

BellRing Case Details

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose materially adverse facts. Specifically, the Complaint alleges that:
(1) the Defendants failed to disclose to investors that its strong sales results did not reflect increased end-consumer demands or brand momentum; 
(2) rather, customers accumulated excess inventory as a safeguard against product shortages that had previously constrained BellRing’s supply; 
(3) once customers gained confidence that product shortages were a thing of the past, they promptly reduced their inventory by selling through existing products and cutting back on new orders; and 
(4) following the destocking, the Company admitted that competitive pressures were materially weakening demand.

What's Next for BellRing Investors?

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: bgandg.com/BRBR. or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in BellRing you have until March 23, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.

No Cost to BellRing Investors

We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman, LLC for BellRing Securities Class Action?

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com

"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.

Follow us for updates on LinkedIn, X, Facebook, or Instagram.

Contact Info

Peretz Bronstein, Esq. or Nathan Miller
Bronstein, Gewirtz & Grossman, LLC
917-590-0911 | [email protected]

Attorney advertising.
Prior results do not guarantee similar outcomes.